Your probably right. It is estimated that Dacogen will be around 250M per year U.S. sales and 250M outside U.S. 500M @ 15 years=7.5B in sales. I believe we see the beginning of this growth in the third quarter updates from Mogn. The current 2006 modest estimate is 25M. I see it closer to 37.5M. I came to this figure from Mogn meeting. 7.2M first shipments and 5.2M reorders per month. If AML approval the next key development. CML and solid tumors studies next.